Amyris has patented a method for genetically engineering Kluyveromyces to produce and secrete antibodies. The method involves modifying the host cell genome, reducing NHEJ activity, and integrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback